Page 52 - EJMO-9-1

Eurasian Journal of Medicine and
Oncology
BRCA VUS in breast cancer in MENA region

doi: 10.1007/S10549-017-4635-4 doi: 10.1515/tjb-2019-0424
36. Abulkhair O, Al Balwi M, Makram O, et al. Prevalence of 47. Gezdirici A, Gökpınar İli E, Değirmenci B, et al. Hereditary
BRCA1 and BRCA2 mutations among high-risk saudi breast-ovarian cancer and BRCA1/BRCA2 variants: A single
patients with breast cancer. J Glob Oncol. 2018;4:1-9. center experience. Acta Oncol Turc. 2021;54(3):264-272.
doi: 10.1200/JGO.18.00066 doi: 10.5505/aot.2021.25348
37. Al Hannan F, Keogh MB, Taha S, Al Buainain L. 48. Duzkale N, Teker HT. The study of genetic and
Characterization of BRCA1 and BRCA2 genetic variants clinicopathological characterisation of Turkish bilateral
in a cohort of Bahraini breast cancer patients using breast cancer patients. Oncol Clin Pract. 2021;17(1):6-13.
next-generation sequencing. Mol Genet Genomic Med.
2019;7(7):e00771. doi: 10.5603/OCP.2020.0026
49. Abulkhair O. Prevalence of BRCA1 and BRCA2 Mutations
doi: 10.1002/mgg3.771
Among High-Risk Saudi Patients With Breast Cancer. J Glob
38. Farra C, Dagher C, Hamadeh L, El Saghir N, Mukherji D. Oncol. 2018;4:1-9.
BRCA mutations in a cohort of Iraqi patients presenting to a
tertiary referral center. BMC Med Genet. 2019;20(1):154-154. doi: 10.1200/JGO.18.00066
doi: 10.1186/s12881-019-0885-9 50. El-Harith EHA, Abdel-Hadi MS, Steinmann D, Dork T.
BRCA1 and BRCA2 mutations in breast cancer patients
39. Jalkh N, Nassar-Slaba J, Chouery E, et al. Prevalance of from Saudi Arabia. Saudi Med J. 2002;23(6):700-704.
BRCA1 and BRCA2 mutations in familial breast cancer
patients in Lebanon. Hered Cancer Clin Pract. 2012;10(1):7. 51. Rebbeck TR, Friebel TM, Friedman E, et al. Mutational
spectrum in a worldwide study of 29,700 families with BRCA1
doi: 10.1186/1897-4287-10-7 or BRCA2 mutations. Hum Mutat. 2018;39(5):593-620.
40. El Saghir NS, Zgheib NK, Assi HA, et al. BRCA1 and BRCA2 doi: 10.1002/humu.23406
mutations in ethnic Lebanese Arab women with high
hereditary risk breast cancer. Oncologist. 2015;20(4):357-364. 52. Calò V, Bruno L, La Paglia L, et al. The clinical significance
of unknown sequence variants in BRCA genes. Cancers.
doi: 10.1634/theoncologist.2014-0364 2010;2(3):1644-1660.
41. Jalkh N, Chouery E, Haidar Z, et al. Next-generation doi: 10.3390/cancers2031644
sequencing in familial breast cancer patients from Lebanon.
BMC Med Genomics. 2017;10(1):8. 53. Stella S, Vitale SR, Massimino M, et al. In silico prediction
of BRCA1 and BRCA2 variants with conflicting clinical
doi: 10.1186/s12920-017-0244-7 interpretation in a cohort of breast cancer patients. Genes.
42. Farra C, Dagher C, Badra R, et al. BRCA mutation screening 2024;15(7):943.
and patterns among high-risk Lebanese subjects. Hered doi: 10.3390/genes15070943
Cancer Clin Pract. 2019;17(1):4.
54. Eggington JM, Bowles KR, Moyes K, et al. A comprehensive
doi: 10.1186/s13053-019-0105-9 laboratory-based program for classification of variants
43. Loizidou M, Marcou Y, Anastasiadou V, Newbold R, of uncertain significance in hereditary cancer genes. Clin
Hadjisavvas A, Kyriacou K. Contribution of BRCA1 and Genet. 2014;86(3):229-237.
BRCA2 germline mutations to the incidence of early-onset doi: 10.1111/cge.12315
breast cancer in Cyprus. Clin Genet. 2007;71(2):165-170.
55. Chikkala R, Bhayal D, Rani N, Modali R, Bhatia K, Dubey B.
doi: 10.1111/j.1399-0004.2007.00747.x Mutational landscape of BRCA gene mutations in Indian
44. Loizidou MA, Hadjisavvas A, Pirpa P, et al. BRCA1 and breast cancer patients: Retrospective insights from a
BRCA2 mutation testing in Cyprus; a population based diagnostic lab. Egypt J Med Hum Genet. 2024;25:101.
study. Clin Genet. 2017;91(4):611-615. doi: 10.1186/s43042-024-00567-6
doi: 10.1111/cge.12886 56. Mehta A, Vasudevan S, Sharma SK, et al. Germline BRCA1
45. Cecener G, Sabour Takanlou L, Sabour Takanlou M, et al. and BRCA2 deleterious mutations and variants of unknown
Clinicopathologic features and genetic characteristics of the clinical significance associated with breast/ovarian
BRCA1/2 mutation in Turkish breast cancer patients. Cancer cancer: A report from North India. Cancer Manag Res.
Genet. 2020;240:23-32. 2018;10:6505-6516.
doi: 10.1016/j.cancergen.2019.10.004 doi: 10.2147/CMAR.S186563
46. Bahsi T, Erdem HB. Spectrum of BRCA1/BRCA2 variants in 57. Wang Y, Bernhardy AJ, Cruz C, et al. The BRCA1-Δ11q
1419 Turkish breast and ovarian cancer patients: A single center alternative splice isoform bypasses germline mutations and
study. Turk J Biochem/Turk Biyokim Derg. 2020;45:83-90. promotes therapeutic resistance to PARP inhibition and

Volume 9 Issue 1 (2025) 44 doi: 10.36922/ejmo.5800